“The unimaginableness of most objects,by reason of their smallness”
R. Hooke, London, 1665
We develop microfluidic based technologies for high throughput drug screening in conjunction with 3-D cell culture. This technology is adaptable to a multitude of applications such as: disease modelling, drug discovery, drug re-purposing, toxicity testing of chemicals, microbial screening and personalized drug optimization. . .